NHS Screening Programmes: What You're Entitled To

Overview

NHS Population Screening, managed by NHS England, runs eleven national screening programmes covering cancer, antenatal and newborn conditions, infectious disease and abdominal aortic aneurysm. Invitations are sent automatically based on age, sex and where applicable other risk factors. Screening is voluntary; participants can decline at any point. The UK National Screening Committee reviews the evidence and recommends which programmes to run.

Cancer screening programmes

Three national cancer screening programmes operate in England: breast (women fifty to seventy, every three years), cervical (women twenty-five to forty-nine every three years, fifty to sixty-four every five years), and bowel (men and women fifty-four onwards, currently being expanded toward fifty, every two years). Invitations are sent automatically by the screening programme administration based on GP-registered address and date of birth.

Antenatal and newborn screening

Antenatal screening offered during pregnancy includes combined screening for Down's syndrome and other chromosomal conditions at eleven to fourteen weeks, the twenty-week anomaly scan, blood tests for infectious diseases, blood group and rhesus, and screening for sickle cell and thalassaemia. Newborn screening covers the newborn hearing test, the heel-prick blood spot test (for nine rare but serious conditions) and the newborn physical examination.

Abdominal Aortic Aneurysm screening

AAA screening is a one-off ultrasound scan offered to men in their sixty-fifth year. The scan checks for an enlargement of the abdominal aorta which, if untreated, can rupture catastrophically. Men over sixty-five not previously screened can request a scan through the local screening service. Women are not routinely screened, as AAA is much rarer in women.

How to opt in or out

Each programme is voluntary. Invitations include information on the test, the benefits and the risks. Patients can decline at any point by responding to the invitation or by contacting the screening service. Declining does not affect any other NHS care. Patients who miss invitations can usually catch up by contacting the local screening team or the GP.

Devolved nation variations: Scotland, Wales, Northern Ireland

NHS arrangements vary across the four UK nations under their respective health and social care frameworks. NHS Scotland operates under the Scottish Government and offers free prescriptions, free dental examinations and somewhat different commissioning arrangements through Health Boards rather than Integrated Care Boards. NHS Wales is the equivalent body in Wales with free prescriptions and integrated public health functions through Public Health Wales.

Health and Social Care Northern Ireland (HSC) is the integrated health and social care provider in Northern Ireland, structured differently from NHS England with combined health and social work commissioning. Prescription charges are free in all three devolved nations. Cross-border patients may move between systems; reciprocal arrangements within the UK mean treatment is generally accessible regardless of which nation issued the patient's NHS number.

Specific service availability, waiting times and commissioning priorities differ between the nations. Patient information is published by NHS Inform (Scotland), NHS 111 Wales and HSC Northern Ireland respectively. Cross-border referrals use established protocols between trusts and Health Boards.

Complaints, advocacy and patient voice

NHS complaints follow the NHS Complaints Regulations 2009. The first step is the provider's own complaints process (most trusts have a complaints team and a Patient Advice and Liaison Service for informal resolution). The trust must acknowledge complaints within three working days and respond substantively within a reasonable period, normally six months.

Unresolved complaints can be escalated to the Parliamentary and Health Service Ombudsman (PHSO), which investigates maladministration in NHS services. Independent advocacy is available free through the Independent NHS Complaints Advocacy Service commissioned by each local authority. Specialist advocacy on clinical negligence is provided by Action Against Medical Accidents (AvMA).

Healthwatch operates at local and national level as the statutory patient voice, gathering feedback and influencing commissioning decisions. The Care Quality Commission (CQC) inspects and rates NHS services from 'Inadequate' to 'Outstanding'; reports are published at cqc.org.uk and offer patient-facing information on service quality. Integrated Care Boards in England commission most NHS services and have public-facing complaints and feedback channels.

Confirming your NHS entitlement on arrival

Most UK residents are entitled to NHS care free at the point of use. The Department of Health and Social Care publishes guidance setting out who is exempt from charges and who is chargeable. Visa holders pay the Immigration Health Surcharge upfront with their visa application and are then entitled to the same NHS access as settled residents for the duration of the visa.

Patients can confirm their NHS number through the NHS App or by phoning the local GP surgery once registered. The NHS number is the identifier across all NHS services including hospitals, dentists, pharmacies and screening programmes. Without an NHS number, services can still treat the patient but record-keeping is harder.

Special groups have specific entitlement protections: asylum seekers and refugees are exempt from hospital charges under the Charges to Overseas Visitors Regulations 2015; victims of modern slavery, looked-after children and certain other groups have specific exemptions. The NHS website nhs.uk/using-the-nhs/about-the-nhs/healthcare-in-england-for-visitors-from-overseas/ sets out the categories.

How screening programmes are designed and approved

The UK National Screening Committee (UK NSC) is the independent body advising ministers on screening programmes. The committee considers evidence on disease burden, test characteristics, treatment effectiveness, and overall benefit versus harm before recommending implementation. Reviews of existing programmes happen on a published schedule; new conditions are considered as evidence emerges.

Once recommended by the UK NSC, programmes are commissioned by NHS England in England (and equivalent bodies in Scotland, Wales and Northern Ireland) and delivered through dedicated screening services. Each programme has detailed quality standards published by the relevant body. Performance is monitored and published; non-compliant programmes can be reformed or in extreme cases discontinued.

The current eleven programmes cover cancer (breast, cervical, bowel), antenatal (combined screening, anomaly scan, infectious diseases, sickle cell and thalassaemia, fetal anomalies), newborn (heel-prick blood spot, hearing, physical examination, infant physical examination), and abdominal aortic aneurysm. Additional surveillance programmes (e.g., diabetic eye screening) sit alongside the main eleven.

Cancer screening: deeper detail by programme

Breast screening invites women aged fifty to seventy-one every three years; women over seventy-one can self-refer. Screening is by mammogram (two views per breast, low-dose X-ray). The Age UK extension trial extending screening to forty-seven and older is in long-term follow-up. Modelling suggests breast screening prevents around thirteen hundred deaths per year in England. Recall for further assessment occurs in around four percent of screens; about ten percent of recalls turn out to be cancer.

Cervical screening invites women aged twenty-five to forty-nine every three years and fifty to sixty-four every five years. The programme moved to HPV primary screening in 2019: the sample is tested first for high-risk HPV, and cytology is performed only if HPV is detected. This approach is more sensitive than cytology alone. Trans men with a cervix and others may be invited or able to self-refer depending on NHS-recorded gender.

Bowel cancer screening uses the FIT (faecal immunochemical test). The current age range is being expanded from fifty-eight to fifty over a phased rollout. The FIT kit is posted to the eligible adult every two years; results come within two weeks. About two percent of FIT results are abnormal and trigger a colonoscopy offer. Colonoscopy at screening centres is delivered by trained endoscopists with high quality standards.

Antenatal and newborn screening detail

Antenatal screening starts at the booking appointment with offers of: combined screening for Down's syndrome, Edwards' syndrome and Patau's syndrome at eleven to fourteen weeks (blood test plus nuchal translucency scan); blood tests for infectious diseases (HIV, syphilis, hepatitis B); maternal blood group and rhesus status; haemoglobinopathy screening for sickle cell and thalassaemia; the twenty-week fetal anomaly ultrasound scan.

Each screening element is optional. The patient receives a screening information leaflet ('Screening tests for you and your baby') and discusses with the midwife. Declining specific screens is supported; the choice does not affect other care. Where a screening result is abnormal, diagnostic testing (NIPT, amniocentesis, chorionic villus sampling) is offered with full discussion of risks and implications.

Newborn screening covers: the heel-prick blood spot test (typically day five) screening for nine rare but serious conditions including phenylketonuria, congenital hypothyroidism, sickle cell disease, cystic fibrosis and several inherited metabolic conditions; the newborn hearing screen (otoacoustic emissions in hospital or community); the newborn physical examination by a midwife or doctor in the first 72 hours and again at six to eight weeks at the GP.

Privacy, consent and how to decline

All NHS screening is voluntary and based on informed choice. Patients receive information about each programme before deciding to attend; the information explains benefits, risks (including overdiagnosis and false positives), and the right to decline. Declining one programme does not affect access to others.

Patient choice extends to specific elements within antenatal screening. A woman can accept the anomaly scan but decline Down's screening; accept HIV testing but decline haemoglobinopathy screening. The midwife discusses each component and documents the patient's choices. Withdrawing consent later in pregnancy is also possible.

Data from screening is held under NHS confidentiality rules. Anonymous aggregated data is used for programme quality monitoring; personally-identifiable data is shared between the screening service, the GP and any onward NHS service for the patient's care. The National Data Opt-Out lets patients opt out of secondary uses of identifiable data (research and planning); the opt-out does not affect screening invitations or results.

How NHS services are commissioned and funded

NHS services in England are commissioned by Integrated Care Boards (ICBs), forty-two regional bodies established in 2022 under the Health and Care Act 2022. Each ICB plans, commissions and pays for NHS services for its population, replacing the previous Clinical Commissioning Groups. Commissioning includes primary care (through the NHS England regional teams in some areas), secondary care from NHS Trusts, community services, mental health services, and continuing healthcare.

Funding flows from the Department of Health and Social Care to NHS England, which allocates to ICBs based on a formula reflecting population size, age structure, deprivation and other factors. ICBs then contract with providers for specific services. The provider mix includes NHS Trusts (the majority of secondary care), GP practices (contracts under the General Medical Services or alternative contracts), independent providers under NHS Standard Contract, and charity-sector providers for some specialised services.

Patient choice operates within the commissioning framework: patients can choose between providers for non-urgent consultant-led care via the e-Referral Service. Specialist services are commissioned at regional or national level for very rare or technically demanding care. Local Authority commissioning covers adult social care, public health functions (smoking cessation, sexual health) and certain children's services.

Quality, safety and patient feedback channels

The Care Quality Commission (CQC) is the independent regulator of all NHS and many independent health and social care services in England. CQC inspections rate services from 'Inadequate' to 'Outstanding' based on five key questions: Are they safe, effective, caring, responsive and well-led? Reports are published at cqc.org.uk and patients can use them when choosing providers.

The National Institute for Health and Care Excellence (NICE) issues guidance on clinical practice, technology appraisals (which drugs and devices the NHS should fund) and quality standards. NICE Technology Appraisal Guidance is mandatory for NHS commissioning in England within ninety days of publication. NICE Clinical Guidelines are advisory but widely followed.

Patient feedback is gathered through the Friends and Family Test (a single-question score at point of care), patient surveys including the National GP Patient Survey published by NHS England, NHS choices/nhs.uk patient reviews, and Healthwatch local and national bodies. Patient feedback informs commissioning decisions, CQC inspection priorities and ongoing improvement at provider level.

Your rights as an NHS patient

The NHS Constitution sets out patient rights under the NHS in England. Key rights include: the right to NHS services free at the point of use except where charges are authorised; the right to access NHS services within maximum waiting times; the right to choice of provider; the right to be involved in decisions about your care; the right to be treated with dignity and respect; the right to confidentiality; the right to access your own health records; the right to complain and have complaints investigated.

Specific waiting-time rights include the eighteen-week right to start consultant-led treatment after referral, the two-week wait for suspected cancer referrals and the four-hour A&E target. These rights are not absolute (the NHS Constitution states they apply 'where clinically appropriate') but are enforceable through complaints and ultimately judicial review in extreme cases. The trust must offer an alternative provider where it cannot meet the eighteen-week target.

Choice rights cover most planned consultant-led care. Patients can choose between providers at the point of GP referral through the NHS e-Referral Service. Choice does not apply to emergency care, mental health detention, or some specialised tertiary services. Patient choice protections are an important lever for those facing long local waits; alternative providers in nearby regions can be accessed under the same NHS terms.

Confidentiality and data rights are governed by the UK GDPR, the Data Protection Act 2018 and NHS-specific guidance. Patients can access their own records through the NHS App or by Subject Access Request. Data sharing for direct care is permitted; secondary uses (research, planning) require either consent or compatibility with the National Data Opt-Out. Specific data flows including the Summary Care Record and Shared Care Record have additional governance.

Provider types: NHS Trusts, Foundation Trusts, private under NHS contract

NHS Trusts deliver hospital and community services. Foundation Trusts have additional autonomy from central government but operate under the same NHS rules. Both are regulated by the Care Quality Commission and NHS England. Each Trust has a chief executive, a board of directors, governors and a clinical leadership team.

Independent (private) sector providers deliver some NHS services under NHS Standard Contract. The arrangement provides NHS-funded care from a private hospital, often for elective surgery to reduce NHS waiting times. The patient experience is NHS-style (NHS funding, NHS waiting-time entitlement) delivered in a private hospital setting. Major independent providers serving NHS patients include Spire, Nuffield Health, Ramsay, Circle and BMI Healthcare in some areas.

Primary care is delivered by GP practices contracted under the General Medical Services contract or Personal Medical Services arrangement. Practices are independent businesses contracted with the NHS, not NHS-owned. Many practices have multiple sites and operate at scale; others are single-site small partnerships. Primary Care Networks (groups of practices serving 30,000 to 50,000 patients) coordinate care across practices and host shared roles including First Contact Physiotherapists and clinical pharmacists.

Community services (district nursing, community physiotherapy, mental health teams, learning disability teams) are commissioned by ICBs and provided by NHS Trusts, social enterprises or charity-sector providers depending on the area. Mental health trusts handle specialist mental health services including inpatient psychiatric care, community mental health teams and specialist services. Ambulance services are provided by ten regional NHS ambulance trusts in England.

NHS technology and digital transformation

NHS digital transformation has accelerated since 2020. The NHS App now covers most major patient touchpoints: appointment booking, prescription ordering, medical record access, NHS 111 online integration. The app is the most widely used UK government-related app and operates under the NHS login security framework. Authentication uses NHS login with identity verification through GOV.UK Verify-style processes.

Electronic Prescription Service routes more than ninety percent of UK prescriptions electronically from prescriber to pharmacy. Patients nominate a pharmacy through the app or the surgery; subsequent prescriptions flow there automatically. The Summary Care Record provides allergies and current medications to clinicians outside the patient's regular practice; the Shared Care Record being rolled out provides the full record across health and social care.

Specialist digital services include the e-Referral Service (specialist appointment booking), the National Care Records Service, the National Cancer Records and the National Diabetes Audit. Behind these patient-facing services sits a complex landscape of clinical systems (SystmOne, EMIS Web in primary care; Cerner, Epic and others in secondary care) that have variable interoperability. NHS England's strategy aims to improve cross-system data flow through APIs and shared standards.

Artificial intelligence and machine learning are being deployed cautiously in NHS settings, primarily in imaging diagnostics (radiology AI for cancer detection), pathology (histology AI), and predictive analytics for service planning. Specific NHS Long Term Plan commitments cover AI adoption with safety and equity safeguards. The MHRA regulates AI as a medical device where it provides clinical decision support.

Disclaimer

This article provides general information for UK residents and newcomers. It is not legal, tax, financial or medical advice. Rules, rates, eligibility criteria and processes change frequently; readers should verify details with the linked primary sources or consult an authorised professional before acting on anything described here. References to specific firms, products or services are illustrative and do not constitute endorsements.

Frequently asked questions

Why have I not been invited for screening?

If eligibility criteria are met (age, sex, GP registration) and an invitation has not arrived, contact the GP surgery to confirm the screening records are up to date. Recent moves and recent GP registrations can delay invitations because the screening system uses GP-registered address records that take time to refresh. The local screening service can also be contacted directly to request an invitation. International newcomers registering with a UK GP may take a few months before screening invitations begin arriving as the records propagate.

Is bowel screening done at home?

Yes. The Faecal Immunochemical Test (FIT) kit is posted to eligible patients with clear instructions and a prepaid return envelope. The patient collects a small stool sample at home using the supplied collection device, places it in the tube and posts it back. Results come within two weeks. Abnormal results trigger an offer of colonoscopy at a screening centre. The home-test format has higher uptake than the predecessor faecal occult blood test because it is simpler and only requires one sample.

Can I have screening privately?

Yes. Private screening for breast, cervical, bowel and other cancers is widely available through private hospitals and clinics. Some include additional tests not currently offered on the NHS (whole-body MRI screening, prostate screening using MRI, lung CT screening for smokers). NHS screening is informed by population evidence and weighs benefits against the risks of overdiagnosis; private screening offers earlier or more frequent testing for those who want it. Cost varies widely; comprehensive private screening packages can cost several thousand pounds.

What is HPV primary screening for cervical cancer?

Cervical screening in England, Scotland and Wales now uses HPV primary screening: the sample is tested for high-risk human papillomavirus types first, and cytology is only done if HPV is detected. This is more sensitive than cytology alone because HPV infection precedes virtually all cervical cancers. HPV-negative samples are at very low risk for the next screening interval. The change took effect in England in December 2019 after pilot evaluation. Northern Ireland has been on a longer rollout.

Will I be invited automatically if I just moved here?

Eligibility is based on GP registration. Once registered with a UK GP, the screening programmes will start sending invitations as the patient becomes eligible by age or pregnancy status. The records can take a few weeks to propagate after registration. If an invitation does not arrive within a few months of registering and you are within the eligible age range, contact the GP surgery to confirm the records are up to date or contact the screening service directly. International women registering with a UK GP in their late twenties or older typically receive cervical screening invitations within three months.